VRAX

Virax Biolabs Group Limited VRAX

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode VRAX QNRX ONCO PXMD REVB ILAG BIAF
6M -41.24 % 281.75 % -31.13 % -50.00 % -85.12 % 65.95 % -83.21 %
YTD -70.49 % 2 952.87 % -93.40 % -99.85 % -95.50 % -34.70 % -90.35 %
1Y -63.97 % 3 919.61 % -99.31 % -99.92 % -96.26 % -42.89 % -95.15 %
3Y -96.27 % 0.49 % -99.92 % -100.00 % -99.99 % -88.93 % -96.59 %
5Y -99.64 % -98.45 % -100.00 % -100.00 % -100.00 % -90.48 % -98.91 %
10Y -99.64 % -99.87 % -100.00 % -100.00 % -100.00 % -90.48 % -98.91 %
From the beginning -99.64 % -99.87 % -100.00 % -100.00 % -100.00 % -90.48 % -98.91 %

Dividend